Works matching IS 08876924 AND DT 2004 AND VI 18 AND IP 6


Results: 27
    1
    2
    3
    4
    5
    6
    7

    Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission - experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).

    Published in:
    Leukemia (08876924), 2004, v. 18, n. 6, p. 1093, doi. 10.1038/sj.leu.2403354
    By:
    • Wendtner, C.-M.;
    • Ritgen, M.;
    • Schweighofer, C. D.;
    • Fingerle-Rowson, G.;
    • Campe, H.;
    • Jäger, G.;
    • Eichhorst, B.;
    • Busch, R.;
    • Diem, H.;
    • Engert, A.;
    • Stilgenbauer, S.;
    • Döhner, H.;
    • Kneba, M.;
    • Emmerich, B.;
    • Hallek, M.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    21
    22
    23
    24
    25
    26
    27